CRISPR Therapeutics to Present New Data on Allogeneic CRISPR-based CAR-T Program and Host Investor … – Markets Insider
|
CRISPR Therapeutics to Present New Data on Allogeneic CRISPR-based CAR-T Program and Host Investor …
Markets Insider ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a genome editing company focused on creating transformative medicine for serious diseases, today announced that the Company … |
